RxDoctor Payments Data

Salman Chaudri, DO

Orthopaedic Surgery · Oak Lawn, ILNPI 1730133711

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Arthrex at 49.3% of the total. 2025 is the largest year on record at $8,701, 5.2 times the $1,664 reported in 2019.

$30,891in general payments, 2019–2025

Across 160 payments — averaging $193.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$15K
  • Medwest Associates$4K
  • Johnson & Johnson$3K
  • Medical Device Business Services, Inc.$3K
  • Lilly USA, LLC$3K
  • Stryker$873
  • plus $2K from 19 others
$39,449in research payments, 2019–2025

Across 3 payments — averaging $13,150 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$39K

What the payments were for

  • Consulting fees$3,15010%
  • Speaking & faculty fees$13,62544%
  • Travel & lodging$3,24911%
  • Food & beverage$7,90226%
  • Education$2,96510%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,891 in reported general payments places this provider in the 80th percentile of 844 orthopaedic surgery providers in Illinois.

See all orthopaedic surgery providers in Illinois →

Medicare billing

Part B allowed, 2024
$155,437
Medicare patients
257
Services billed
13,064

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen42$1,084
Celecoxib27$784
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$487
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$355
Meloxicam67$303
Cyclobenzaprine Hcl42$221
Tramadol Hcl21$102
Methylprednisolone17$89
Naproxen12$66
Amoxicillin12$32

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Oak Lawn

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →